{
  "report": {
    "report_id": "REP-20251217-f3aa37",
    "title": "Remdesivir \u2013 COVID-19 \u2013 India (Repurposing Scan)",
    "generated_at": "2025-12-17T11:53:07.140363",
    "format": "pdf",
    "sections": {
      "executive_summary": [
        "Remdesivir (INN) is used in the treatment of COVID-19 with multiple studies published recently focusing on its clinical use, safety (including bradycardia incidence), and outcomes in patients with comorbidities such as chronic kidney disease. Indian news highlights legal and regulatory issues related to remdesivir supply and use during the pandemic. Authoritative guidelines from WHO and NICE are available for COVID-19 but no exclusive remdesivir-specific guidelines were found. Overall, evidence supports the use of remdesivir in COVID-19 management with considerations on safety and supply in the Indian context."
      ],
      "clinical_trials": {
        "summary": {
          "active": 3,
          "completed": 2,
          "phase_distribution": {
            "Observational": 1,
            "Phase 1": 0,
            "Phase 2": 2,
            "Phase 3": 1,
            "Phase 4": 0
          }
        },
        "highlights": [
          "No Phase III trials identified in India"
        ],
        "top_trials": [
          {
            "trial_id": "NCT04610541",
            "title": "Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients",
            "phase": "Phase 3",
            "status": "Active",
            "sponsor": "University of Pecs",
            "locations": [
              "Hungary"
            ],
            "start_date": "2020-10-12"
          },
          {
            "trial_id": "NCT04647695",
            "title": "An Open-label Randomized Controlled Trial on Interferon \u03b2-1b and Remdesivir Combination Versus Remdesivir as Treatment for COVID-19 Infection",
            "phase": "Phase 2",
            "status": "Active",
            "sponsor": "The University of Hong Kong",
            "locations": [
              "Hong Kong"
            ],
            "start_date": "2020-11-20"
          },
          {
            "trial_id": "NCT04345419",
            "title": "Remdesivir in COVID-19 Treatment: A Randomised Trial",
            "phase": "Phase 2",
            "status": "Completed",
            "sponsor": "Tanta University",
            "locations": [
              "Egypt"
            ],
            "start_date": "2020-06-16"
          },
          {
            "trial_id": "NCT04582266",
            "title": "Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States",
            "phase": "Observational",
            "status": "Completed",
            "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
            "locations": [
              "United States"
            ],
            "start_date": "2021-03-31"
          },
          {
            "trial_id": "NCT04560231",
            "title": "Is Remdesivir a Possible Therapeutic Option for SARS-CoV-2 : An Interventional Study",
            "phase": "EARLY_Phase 1",
            "status": "Active",
            "sponsor": "Lahore General Hospital",
            "locations": [
              "Pakistan"
            ],
            "start_date": "2020-06-01"
          }
        ]
      },
      "guidelines_and_literature": {
        "guideline_points": [
          {
            "source": "WHO Guidelines",
            "publisher": "World Health Organization",
            "date": "2024-01-01",
            "recommendation": "Generic authoritative health guideline source (disease-specific guideline not mapped in MVP).",
            "url": "https://www.who.int/publications/guidelines"
          },
          {
            "source": "NICE Guidelines",
            "publisher": "National Institute for Health and Care Excellence (NICE)",
            "date": "2024-01-01",
            "recommendation": "Generic authoritative guideline repository (disease-specific guidance not mapped in MVP).",
            "url": "https://www.nice.org.uk/guidance"
          }
        ],
        "publication_points": [
          {
            "pmid": "39816292",
            "title": "Successful Sequential Treatment From Remdesivir to Molnupiravir for Prolonged COVID-19 in a Patient With Follicular Lymphoma and Renal Pelvic Carcinoma: A Case Report.",
            "journal": "Cureus",
            "year": 2024,
            "key_finding": "Title suggests clinical use of remdesivir for prolonged COVID-19 in a complex patient case."
          },
          {
            "pmid": "39811032",
            "title": "Incidence of bradycardia with the use of remdesivir for coronavirus disease of 2019 and risk factor analysis.",
            "journal": "International journal of critical illness and injury science",
            "year": 2024,
            "key_finding": "Title suggests investigation of bradycardia incidence related to remdesivir use in COVID-19."
          },
          {
            "pmid": "39739156",
            "title": "Treatment pattern and clinical outcomes of remdesivir in hospitalized COVID-19 patients with severe chronic kidney disease: a database analysis of acute care hospitals in Japan.",
            "journal": "Clinical and experimental nephrology",
            "year": 2025,
            "key_finding": "Title indicates analysis of remdesivir treatment outcomes in COVID-19 patients with severe kidney disease."
          }
        ],
        "news_signals": [
          {
            "headline": "Black marketing Remdesivir in Covid: Two get two years in jail - Times of India",
            "publisher": "Times of India",
            "date": "2025-05-28",
            "takeaway": "Report on legal actions against black marketing of remdesivir during the COVID-19 pandemic in India.",
            "url": "https://news.google.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?oc=5"
          },
          {
            "headline": "Coronavirus: Pune Municipal Corporation Issues Guidelines for Use of Remdesivir in COVID-19 Patients - The Bridge Chronicle",
            "publisher": "The Bridge Chronicle",
            "date": "2025-05-29",
            "takeaway": "Local government entity in Pune issued usage guidelines for remdesivir in COVID-19 management.",
            "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxORkZIRTJWZXN1RElqS25TSkRid29pb3M4dlRGdU1Lbzd5TU51QUQwVGhUUlZQMkhQMDdma3Jxa2FxRW9mcWJPVmtkVXlDRWg5RmR6S3VfY01TSzhqaUJLcldXbldzcndlX0g4SmNxQVBOZGlYSFduaTJQLU9UMlR0QnBveHppUUZPR01xcVZ0a0RzclJpTWhrUGV0Nzl0NFhFYlHSAa8BQVVfeXFMTUlxYnQ5XzhoRkV5Q0QwcUNhUzRhSDRpOVNzb050UnRYaE9fWFVjalFraEhXSVZNaVJDeTl4RVdUYmk3X1h6UmU5MzJ5LVdvWVFPWkFLTFh1RnVucUtMSHBsMmdCTVRvcUJVUjdxdVQ4R0hHU1k0bVVaN01pbkpxRkxCdXJXX1EwbkktWEtTLXpaSEZNY0czRkloNFBSbmFPNFF6RThYb3ZuUzhoWUJ4TQ?oc=5"
          },
          {
            "headline": "What does the widespread use of Remdesivir in COVID-19 management in India and short supply of it teach us? - orfonline.org",
            "publisher": "orfonline.org",
            "date": "2021-05-06",
            "takeaway": "Article reflecting on the implications of extensive remdesivir use and supply shortages in India during COVID-19.",
            "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQT0x1WU9UOFFhMkhmN3NsS3ZzeHpTR3FGVmVNa2E3RnBGTjhHcG5Dc3hlTFNkYU5CQVVnbTFJNld4SWlzTkVKYU1LTEFjaFZ5Q0pscnFYMURBSENUQ19QLWhhdkluRnNoMGwtX1Jad3BaOVJzcXZuRk15QWh0R0QxMm1hSmZhR1dtVUR0U1FnVFh6MDRxTzVQVg?oc=5"
          },
          {
            "headline": "COVID digest: India bans export of remdesivir treatment drug - DW",
            "publisher": "DW",
            "date": "2021-04-11",
            "takeaway": "Report on Indian government banning remdesivir exports during the COVID-19 pandemic to ensure local supply.",
            "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeUc5MXhhUXh4OXhQbE5Ob1ROWEtscTdxU0xyYksxZml3c1hudWNwRmdieFVOU3oybnN5LWpiUUVpR05ad3QxNl9ua3JmdW5SOUN0Qkp6LTNrMkRKdFA0M1JTRVBQd0c5cGdNSktxX0VybnlaMWVFQkJiNG5Cb0dDQXFETDVGMFdkMEpQS0Y1cFctWWNXNUk5anR6bFVkMlI3UjVZOGxZaFd4dFXSAasBQVVfeXFMTlRZOUFsTWdyNVlueEdTdFZrc21KMENTbGNpQlBMZEgxc1Bydy15SnBUNldQVmxUZGFoaGVSQlo1VENOX2QwekVWeXNNSkoyc3BZSWpsM0ZTeE9uSG1Zb1A2UHJITEowSHNIQ0xIVDVSbXg1ZU1MSjhFVzZwRzE0VHI5SjNfWUU2YWUzejZTZVhIZi1raDNBTUNGdFdxX2hVVUdqdzVQME5MdDZj?oc=5"
          }
        ]
      },
      "repurposing_options": [
        {
          "option": "Targeted subgroup usage",
          "rationale": "Remdesivir (INN) is used in the treatment of COVID-19 with multiple studies published recently focusing on its clinical use, safety (including bradycardia incidence), and outcomes in patients with comorbidities such as chronic kidney disease. Indian news highlights legal and regulatory issues related to remdesivir supply and use during the pandemic. Authoritative guidelines from WHO and NICE are available for COVID-19 but no exclusive remdesivir-specific guidelines were found. Overall, evidence supports the use of remdesivir in COVID-19 management with considerations on safety and supply in the Indian context.",
          "evidence": [
            "WHO Guidelines",
            "NICE Guidelines"
          ]
        }
      ],
      "risks_and_gaps": [
        "Limited late-stage clinical evidence",
        "Geography-specific data gaps for India"
      ],
      "references": [
        {
          "type": "guideline",
          "label": "WHO Guidelines",
          "url": "https://www.who.int/publications/guidelines"
        },
        {
          "type": "guideline",
          "label": "NICE Guidelines",
          "url": "https://www.nice.org.uk/guidance"
        },
        {
          "type": "publication",
          "label": "PMID:39816292",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39816292/"
        },
        {
          "type": "publication",
          "label": "PMID:39811032",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39811032/"
        },
        {
          "type": "publication",
          "label": "PMID:39739156",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39739156/"
        },
        {
          "type": "trial",
          "label": "NCT04610541",
          "url": "https://clinicaltrials.gov/study/NCT04610541"
        },
        {
          "type": "trial",
          "label": "NCT04647695",
          "url": "https://clinicaltrials.gov/study/NCT04647695"
        },
        {
          "type": "trial",
          "label": "NCT04345419",
          "url": "https://clinicaltrials.gov/study/NCT04345419"
        },
        {
          "type": "trial",
          "label": "NCT04582266",
          "url": "https://clinicaltrials.gov/study/NCT04582266"
        },
        {
          "type": "trial",
          "label": "NCT04560231",
          "url": "https://clinicaltrials.gov/study/NCT04560231"
        }
      ]
    },
    "warnings": [
      "FTO requested but not executed in MVP",
      "Supply view requested but not executed in MVP"
    ],
    "file": {
      "type": "pdf",
      "path": "reports/remdesivir_covid-19_india.pdf"
    }
  }
}